Adverse Events

Ranexa® has been studied in multiple clinical trials, which provide important information on its most common adverse events reported in angina patients and its use in special populations.

In controlled clinical trials of angina patients, the most frequently reported treatment-emergent adverse reactions (>4% and more common on Ranexa than on placebo) were dizziness, headache, constipation, and nausea.1

  • 5.5% of patients on Ranexa experienced headache
  • 0.5% of patients discontinued therapy due to headache

Most Common Adverse Reactions

*Dizziness may be dose related.

Icon of people in a circle

Ranexa Clinical Trials

Review the CARISA and TERISA clinical trials to learn how Ranexa may help reduce the symptoms of chronic angina.

View Clinical Data
Safety data icon of a checkmark

Safety

Learn about safety data from the Ranexa clinical trials, including use in special populations.

Review Safety & Tolerability
Financial Assistance icon of a dollar bill

Financial Assistance

Ranexa Connect™ is a financial assistance resource for patients with a Ranexa prescription.

Ranexa Connect is pleased to announce iAssist, a program to help get your patients started on Ranexa faster. The program offers online patient enrollment, electronic signatures, as well as real-time pharmacy benefit check and eligibility for financial assistance.

Get Started Now
Reference:

1. Ranexa [package insert]. Foster City, CA: Gilead Sciences, Inc.; January 2016.

Important Safety Information
Contraindications